Abbott makes pharmaceuticals, diagnostic tests, nutritional products, and medical devices for healthcare providers and consumers. It last closed at $103.00 on Nov 20, down 0.84% on the day. The next earnings report for ABT is expected around Thu, Jan 21, 2027. For the quarter ended Sep 2026, ABT reported EPS of $0.53 on revenue of $13.01B, with revenue up 14.5% from a year ago. Over its last 8 reports the stock moved an average of 5.5% the session after earnings. Over the last 12 months ABT insiders bought $4.4M of stock on the open market and sold $47.9M, according to SEC Form 4 filings.
AI Auto Pilots
Is ABT in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold ABT.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on ABTStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
ABT · as of the Nov 20 close · updated each morning
Moving sideways
The stock is 4% below its 20 day and 1% below its 50 day average. It is 2% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 42). The nearest support is the swing low (Jul 31) at $102.89, and the nearest resistance the Pivot at $103.77.
Short trendNeutral
Long trendNeutral
MomentumWeak
StretchNormal
VolatilityHigh, 2.8%/day
Key levels
$129.8552 week high+26.1%
$107.4820 day average+4.3%
$104.73Pivot R1+1.7%
$104.60100 day average+1.6%
$104.54Swing high (Sep 22)+1.5%
$103.8950 day average+0.9%
$103.77Pivot+0.7%
$103.00Last close
$102.89Swing low (Jul 31)−0.1%
$102.03Pivot S1−0.9%
$101.45200 day average−1.5%
$81.9752 week low−20.4%
Indicators
RSI (14)
41.89
Middle of its range
Neutral
MACD
0.11
Below its signal line
Bearish
Stochastic
4.9
Near the bottom of its range
Oversold
ADX (14)
17.0
No clear trend
Williams %R
-98.6
Oversold below −80, overbought above −20
Oversold
CCI (20)
-86.0
Oversold below −100, overbought above 100
Neutral
Rate of change
−6.3%
Change over 10 sessions
Bearish
ATR (14)
$2.91
Typical daily range, 2.8% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Above
Moving sideways
Short trendNeutral
Long trendBearish
MomentumImproving
StretchNormal
VolatilityHigh, 6.1%/day
Key levels
$129.8552 week high+26.1%
$107.4820 day average+4.3%
$104.73Pivot R1+1.7%
$104.60100 day average+1.6%
$104.54Swing high (Sep 22)+1.5%
$103.8950 day average+0.9%
$103.77Pivot+0.7%
$103.00Last close
$102.89Swing low (Jul 31)−0.1%
$102.03Pivot S1−0.9%
$101.45200 day average−1.5%
$81.9752 week low−20.4%
Indicators
RSI (14)
48.74
Middle of its range
Neutral
MACD
0.74
Above its signal line
Bullish
Stochastic
54.3
Middle of its range
Neutral
ADX (14)
17.2
No clear trend
Williams %R
-64.4
Oversold below −80, overbought above −20
Neutral
CCI (20)
8.4
Oversold below −100, overbought above 100
Neutral
Rate of change
+1.0%
Change over 10 sessions
Bullish
ATR (14)
$6.29
Typical daily range, 6.1% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for ABT
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how ABT did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow ABT usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for ABTHow many large options trades hit ABT, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in ABT in the last 90 days.
From SEC Form 4 filings by ABT's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
For membersMonth by month buying, shares and the average price paid each month are shown to AI Starter and AI Pro members.
From the company's 10-Q filed Nov 4, 2026. Quarters are the company's own fiscal quarters. Yield and % of value use the latest close. Buybacks are not a forecast: in our testing, the biggest buyers did about the same as the average S&P 500 stock.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ABT is in one of them and how their past ABT trades turned out.
From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data
About Abbott Laboratories
Abbott is a health care company based in Abbott Park, Illinois. It develops, makes, and sells products in four main areas: established pharmaceutical products, diagnostic systems and tests, nutritional products, and medical devices. Its customers include hospitals, clinics, laboratories, pharmacies, wholesalers, healthcare providers, government agencies, and consumers, and it sells in markets around the world.